These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28924200)

  • 1. Controllable Moderate Heating Enhances the Therapeutic Efficacy of Irreversible Electroporation for Pancreatic Cancer.
    Edelblute CM; Hornef J; Burcus NI; Norman T; Beebe SJ; Schoenbach K; Heller R; Jiang C; Guo S
    Sci Rep; 2017 Sep; 7(1):11767. PubMed ID: 28924200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moderate Heat Application Enhances the Efficacy of Nanosecond Pulse Stimulation for the Treatment of Squamous Cell Carcinoma.
    Edelblute CM; Guo S; Hornef J; Yang E; Jiang C; Schoenbach K; Heller R
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818802305. PubMed ID: 30253713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Immunologic Response of Irreversible Electroporation versus Cryoablation in a Rodent Model of Pancreatic Cancer.
    White SB; Zhang Z; Chen J; Gogineni VR; Larson AC
    J Vasc Interv Radiol; 2018 Dec; 29(12):1764-1769. PubMed ID: 30316676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of contribution of mild and moderate hyperthermia to thermal ablation and sensitization of irreversible electroporation of pancreatic cancer cells.
    Agnass P; Rodermond HM; van Veldhuisen E; Vogel JA; Ten Cate R; van Lienden KP; van Gulik TM; Franken NAP; Oei AL; Kok HP; Besselink MG; Crezee J
    J Therm Biol; 2023 Jul; 115():103619. PubMed ID: 37437370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of irreversible electroporation (IRE) for locally advanced pancreatic cancer: a systematic review of safety and efficacy.
    Ansari D; Kristoffersson S; Andersson R; Bergenfeldt M
    Scand J Gastroenterol; 2017 Nov; 52(11):1165-1171. PubMed ID: 28687047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical and Chemical Enhancement of and Adaptive Resistance to Irreversible Electroporation of Pancreatic Cancer.
    Shao Q; Liu F; Chung C; Elahi-Gedwillo K; Provenzano PP; Forsyth B; Bischof JC
    Ann Biomed Eng; 2018 Jan; 46(1):25-36. PubMed ID: 28983745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irreversible electroporation promotes a pro-inflammatory tumor microenvironment and anti-tumor immunity in a mouse pancreatic cancer model.
    Imran KM; Brock RM; Beitel-White N; Powar M; Orr K; Aycock KN; Alinezhadbalalami N; Salameh ZS; Eversole P; Tintera B; Markov Madanick J; Hendricks-Wenger A; Coutermarsh-Ott S; Davalos RV; Allen IC
    Front Immunol; 2024; 15():1352821. PubMed ID: 38711517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermodynamic profiling during irreversible electroporation in porcine liver and pancreas: a case study series.
    Agnass P; van Veldhuisen E; Vogel JA; Kok HP; de Keijzer MJ; Schooneveldt G; de Haan LR; Klaessens JH; Scheffer HJ; Meijerink MR; van Lienden KP; van Gulik TM; Heger M; Crezee J; Besselink MG
    J Clin Transl Res; 2020 Apr; 5(3):109-132. PubMed ID: 32617426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review of irreversible electroporation in the treatment of advanced pancreatic cancer.
    Moir J; White SA; French JJ; Littler P; Manas DM
    Eur J Surg Oncol; 2014 Dec; 40(12):1598-604. PubMed ID: 25307210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient Derived Xenografts Expand Human Primary Pancreatic Tumor Tissue Availability for
    Brock RM; Beitel-White N; Coutermarsh-Ott S; Grider DJ; Lorenzo MF; Ringel-Scaia VM; Manuchehrabadi N; Martin RCG; Davalos RV; Allen IC
    Front Oncol; 2020; 10():843. PubMed ID: 32528898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.
    Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2607-2618. PubMed ID: 28871458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irreversible electroporation ablation overcomes tumor-associated immunosuppression to improve the efficacy of DC vaccination in a mice model of pancreatic cancer.
    Yang J; Eresen A; Shangguan J; Ma Q; Yaghmai V; Zhang Z
    Oncoimmunology; 2021 Feb; 10(1):1875638. PubMed ID: 33643692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study.
    Scheffer HJ; Vroomen LG; de Jong MC; Melenhorst MC; Zonderhuis BM; Daams F; Vogel JA; Besselink MG; van Kuijk C; Witvliet J; de van der Schueren MA; de Gruijl TD; Stam AG; van den Tol PM; van Delft F; Kazemier G; Meijerink MR
    Radiology; 2017 Feb; 282(2):585-597. PubMed ID: 27604035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible electroporation ablation: is all the damage nonthermal?
    Faroja M; Ahmed M; Appelbaum L; Ben-David E; Moussa M; Sosna J; Nissenbaum I; Goldberg SN
    Radiology; 2013 Feb; 266(2):462-70. PubMed ID: 23169795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HyCHEED System for Maintaining Stable Temperature Control during Preclinical Irreversible Electroporation Experiments at Clinically Relevant Temperature and Pulse Settings.
    Agnass P; Rodermond HM; Zweije R; Sijbrands J; Vogel JA; van Lienden KP; van Gulik TM; van Veldhuisen E; Franken NAP; Oei AL; Kok HP; Besselink MG; Crezee J
    Sensors (Basel); 2020 Oct; 20(21):. PubMed ID: 33142821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulse timing during irreversible electroporation achieves enhanced destruction in a hindlimb model of cancer.
    Jiang C; Shao Q; Bischof J
    Ann Biomed Eng; 2015 Apr; 43(4):887-95. PubMed ID: 25269611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model.
    Shankara Narayanan JS; Hayashi T; Erdem S; McArdle S; Tiriac H; Ray P; Pu M; Mikulski Z; Miller A; Messer K; Carson D; Schoenberger S; White RR
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36634919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer cells ablation with irreversible electroporation.
    Miller L; Leor J; Rubinsky B
    Technol Cancer Res Treat; 2005 Dec; 4(6):699-705. PubMed ID: 16292891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Irreversible electroporation in the treatment of locally advanced pancreatic cancer].
    Záruba P; Hoskovec D; Lacman J; Hořejš J; Krška Z; Ryska M
    Rozhl Chir; 2015 Dec; 94(12):504-9. PubMed ID: 26767900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irreversible electroporation of the porcine kidney: Temperature development and distribution.
    Wagstaff PG; de Bruin DM; van den Bos W; Ingels A; van Gemert MJ; Zondervan PJ; Verdaasdonk RM; van Lienden KP; van Leeuwen TG; de la Rosette JJ; Laguna Pes MP
    Urol Oncol; 2015 Apr; 33(4):168.e1-7. PubMed ID: 25557146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.